Emanuela Azara

Dr. Emanuela Azara

CNR Institute of Biomolecular Chemistry, National Research Council, Via Marzolo 1, Padua, Italy
orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 September 2014 in Journal of Food Composition and Analysis
Verified
Journal Article
Closed access
Angela FaddaAngela Fadda
Angela Fadda
MSMaria Serra
Maria Serra
MMMaria Giovanna Molinu
Maria Giovanna Molinu
EAEmanuela Azara
Emanuela Azara
Antonio BarberisAntonio Barberis
Antonio Barberis
Daniele SANNADaniele SANNA
Daniele SANNA

6 March 2011 in Molecular Plant Pathology
Verified
Journal Article
Open access
PDF file
BSBarbara Scherm
Barbara Scherm
MOMarcella Orrù
Marcella Orrù
VBVirgilio Balmas
Virgilio Balmas
FSFrancesca Spanu
Francesca Spanu
EAEmanuela Azara
Emanuela Azara
Quirico MigheliQuirico Migheli
Quirico Migheli
SUMMARY: An RNA silencing construct was used to alter mycotoxin production in the plant pathogenic fungus Fusarium culmorum , the incitant of crown and foot rot on wheat. The transformation of a wild‐type strain and its nitrate reductase‐deficient mutant with inverted repeat transgenes (IRTs) containing sequences corresponding to the trichothecene regulatory gene TRI6 was achieved using hygromycin B resistance as a selectable marker. Southern analysis revealed a variety of integration patterns of the TRI6 IRT. One transformant underwent homologous recombination with deletion of the endogenous TRI6 gene, whereas, in another transformant, the TRI6 IRT was not integrated into the genome. The TRI6 IRT did not alter the physiological characteristics, such as spore production, pigmentation or growth rate, on solid media. In most transformants, a high TRI6 amplification signal was detected by quantitative reverse transcription‐polymerase chain reaction, corresponding to a TRI6 ‐hybridizing smear of degraded fragments by Northern analysis, whereas TRI5 expression decreased compared with the respective nontransformed strain. Four transformants showed increased TRI5 expression, which was correlated with a dramatic (up to 28‐fold) augmentation of deoxynivalenol production. Pathogenicity assays on durum wheat seedlings confirmed that impairment of deoxynivalenol production in the TRI6 IRT transformants correlated with a loss of virulence, with decreased disease indices ranging from 40% to 80% in nine silenced strains, whereas the overproducing transformants displayed higher virulence compared with the wild‐type.

22 May 2014 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
GPGiovanna Pani
Giovanna Pani
BSBarbara Scherm
Barbara Scherm
EAEmanuela Azara
Emanuela Azara
VBVirgilio Balmas
Virgilio Balmas
ZJZahra Jahanshiri
Zahra Jahanshiri
GDGiovanna Delogu
Giovanna Delogu


31 March 2020 in Biomolecules
Verified
Journal Article
Open access
PDF file
AFAndrea Floris
Andrea Floris
MMMichael Mazarei
Michael Mazarei
XYXi Yang
Xi Yang
ARAaron Robinson
Aaron Robinson
JZJennifer Zhou
Jennifer Zhou
Maria Lauda TomasiMaria Lauda Tomasi
Maria Lauda Tomasi
Existing therapeutic strategies for breast cancer are limited by tumor recurrence and drug-resistance. Antioxidant plant-derived compounds such as flavonoids reduce adverse outcomes and have been identified as a potential source of antineoplastic agent with less undesirable side effects. Here, we describe the novel regulation of fatty-acid synthase (FASN), the key enzyme in de novo fatty-acid synthesis, whereby Vitis vinifera L. cv Vermentino leaf hydroalcoholic extract lowers its protein stability that is regulated by small ubiquitin-like modifier (SUMO)ylation. The phenolic compounds characterization was performed by liquid chromatography–mass spectrometry (LC–MS), whereas mass spectrometry (LC–MS/MS), Western blotting/co-immunoprecipitation (Co-IP) and RT-PCR, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), clonogenicity assays, and FACS analysis were used to measure the expression of targets and tumorigenicity. Vermentino extract exhibits antitumorigenic effects, and we went on to determine that FASN and ubiquitin-conjugating enzyme 9 (UBC9), the sole E2 enzyme required for SUMOylation, were significantly reduced. Moreover, FASN was found SUMOylated in human breast cancer tissues and cell lines, and lack of SUMOylation caused by SUMO2 silencing reduced FASN protein stability. These results suggest that SUMOylation protects FASN against proteasomal degradation and may exert oncogenic activity through alteration of lipid metabolism, whereas Vermentino extract inhibits these effects which supports the additional validation of the therapeutic value of this compound in breast cancer.